2,606
Participants
Start Date
December 29, 2020
Primary Completion Date
February 26, 2026
Study Completion Date
February 26, 2026
Meningococcal Group B Vaccine
A combination vaccine consisting of rMenB and OMV NZ.
Placebo
150mM sodium chloride (0.9% saline solution).
Harlem Prevention Center, Columbia University, Mailman School of Public Health, New York
The Thai Red Cross AIDS Research Centre, Bangkok
Armed Forces Research Institute of Medical Sciences - Royal Thai Army Clinical Research Center, Bangkok
University of Pennsylvania HIV/AIDS Prevention Research Division, Philadelphia
Walter Reed National Military Medical Center, Bethesda
Emory University School of Medicine - The Ponce de Leon Center, Atlanta
Emory University Hospital Midtown - Emory Clinic Infectious Diseases, Atlanta
University of Alabama at Birmingham School of Medicine - Infectious Disease, Birmingham
University of Illinois at Chicago College of Medicine - Division of Infectious Diseases, Chicago
LSU - CrescentCare Sexual Health Center, New Orleans
UCLA Clinical AIDS Research and Education (CARE) Center, Los Angeles
SFDPH Bridge HIV Center, San Francisco
Malawi Clinical Research Site, Lilongwe, Lilongwe
National Institute of Allergy and Infectious Diseases (NIAID)
NIH